vs
LINKBANCORP, Inc.（LNKB）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是LINKBANCORP, Inc.的1.6倍（$75.5M vs $46.0M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs 7.3%），LINKBANCORP, Inc.自由现金流更多（$23.8M vs $14.4M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 6.6%）
LINKBANCORP是一家总部位于美国的银行控股公司，主要为宾夕法尼亚州地区的个人消费者、小微企业和中型企业提供零售与商业银行服务，涵盖存款账户、贷款产品、财富管理解决方案及数字银行服务等核心业务。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
LNKB vs PBYI — 直观对比
营收规模更大
PBYI
是对方的1.6倍
$46.0M
营收增速更快
PBYI
高出20.5%
7.3%
自由现金流更多
LNKB
多$9.4M
$14.4M
两年增速更快
PBYI
近两年复合增速
6.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $46.0M | $75.5M |
| 净利润 | $2.9M | — |
| 毛利率 | — | 69.3% |
| 营业利润率 | 8.5% | 22.7% |
| 净利率 | 6.4% | — |
| 营收同比 | 7.3% | 27.7% |
| 净利润同比 | -61.2% | — |
| 每股收益（稀释后） | $0.08 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LNKBPBYI
| Q4 25 | $46.0M | $75.5M | ||
| Q3 25 | $44.8M | $54.5M | ||
| Q2 25 | $42.3M | $52.4M | ||
| Q1 25 | $53.4M | $46.0M | ||
| Q4 24 | $42.9M | $59.1M | ||
| Q3 24 | $42.9M | $80.5M | ||
| Q2 24 | $41.3M | $47.1M | ||
| Q1 24 | $40.5M | $43.8M |
净利润LNKBPBYI
| Q4 25 | $2.9M | — | ||
| Q3 25 | $7.8M | $8.8M | ||
| Q2 25 | $7.4M | $5.9M | ||
| Q1 25 | $15.3M | $3.0M | ||
| Q4 24 | $7.6M | — | ||
| Q3 24 | $7.1M | $20.3M | ||
| Q2 24 | $5.8M | $-4.5M | ||
| Q1 24 | $5.7M | $-4.8M |
毛利率LNKBPBYI
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | — | 75.5% |
营业利润率LNKBPBYI
| Q4 25 | 8.5% | 22.7% | ||
| Q3 25 | 22.3% | 17.6% | ||
| Q2 25 | 22.4% | 12.7% | ||
| Q1 25 | 36.0% | 8.7% | ||
| Q4 24 | 22.6% | 22.6% | ||
| Q3 24 | 21.3% | 27.4% | ||
| Q2 24 | 18.0% | -4.6% | ||
| Q1 24 | 18.1% | -5.3% |
净利率LNKBPBYI
| Q4 25 | 6.4% | — | ||
| Q3 25 | 17.5% | 16.2% | ||
| Q2 25 | 17.5% | 11.2% | ||
| Q1 25 | 28.7% | 6.5% | ||
| Q4 24 | 17.7% | — | ||
| Q3 24 | 16.5% | 25.2% | ||
| Q2 24 | 14.1% | -9.6% | ||
| Q1 24 | 14.1% | -11.0% |
每股收益（稀释后）LNKBPBYI
| Q4 25 | $0.08 | $0.26 | ||
| Q3 25 | $0.21 | $0.17 | ||
| Q2 25 | $0.20 | $0.12 | ||
| Q1 25 | $0.41 | $0.06 | ||
| Q4 24 | $0.21 | $0.40 | ||
| Q3 24 | $0.19 | $0.41 | ||
| Q2 24 | $0.16 | $-0.09 | ||
| Q1 24 | $0.15 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $52.3M | $97.5M |
| 总债务越低越好 | $177.3M | $22.7M |
| 股东权益账面价值 | $306.4M | $130.3M |
| 总资产 | $3.1B | $216.3M |
| 负债/权益比越低杠杆越低 | 0.58× | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资LNKBPBYI
| Q4 25 | $52.3M | $97.5M | ||
| Q3 25 | $194.2M | $94.4M | ||
| Q2 25 | $155.1M | $96.0M | ||
| Q1 25 | $220.2M | $93.2M | ||
| Q4 24 | $166.1M | $101.0M | ||
| Q3 24 | $191.2M | $96.7M | ||
| Q2 24 | $181.7M | $96.8M | ||
| Q1 24 | $172.3M | $107.2M |
总债务LNKBPBYI
| Q4 25 | $177.3M | $22.7M | ||
| Q3 25 | $102.3M | $34.0M | ||
| Q2 25 | $102.3M | $45.3M | ||
| Q1 25 | $102.7M | $56.7M | ||
| Q4 24 | $112.5M | $68.0M | ||
| Q3 24 | $102.4M | $79.3M | ||
| Q2 24 | $102.3M | $90.7M | ||
| Q1 24 | $102.2M | $102.0M |
股东权益LNKBPBYI
| Q4 25 | $306.4M | $130.3M | ||
| Q3 25 | $305.5M | $115.3M | ||
| Q2 25 | $298.0M | $104.7M | ||
| Q1 25 | $294.1M | $97.1M | ||
| Q4 24 | $280.2M | $92.1M | ||
| Q3 24 | $277.4M | $71.1M | ||
| Q2 24 | $271.4M | $48.5M | ||
| Q1 24 | $268.2M | $51.0M |
总资产LNKBPBYI
| Q4 25 | $3.1B | $216.3M | ||
| Q3 25 | $3.1B | $202.9M | ||
| Q2 25 | $2.9B | $194.9M | ||
| Q1 25 | $2.9B | $196.2M | ||
| Q4 24 | $2.9B | $213.3M | ||
| Q3 24 | $2.9B | $220.7M | ||
| Q2 24 | $2.9B | $205.0M | ||
| Q1 24 | $2.8B | $214.1M |
负债/权益比LNKBPBYI
| Q4 25 | 0.58× | 0.17× | ||
| Q3 25 | 0.33× | 0.30× | ||
| Q2 25 | 0.34× | 0.43× | ||
| Q1 25 | 0.35× | 0.58× | ||
| Q4 24 | 0.40× | 0.74× | ||
| Q3 24 | 0.37× | 1.12× | ||
| Q2 24 | 0.38× | 1.87× | ||
| Q1 24 | 0.38× | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $25.3M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $23.8M | $14.4M |
| 自由现金流率自由现金流/营收 | 51.7% | 19.1% |
| 资本支出强度资本支出/营收 | 3.2% | 0.0% |
| 现金转化率经营现金流/净利润 | 8.59× | — |
| 过去12个月自由现金流最近4个季度 | $55.3M | $41.7M |
8季度趋势，按日历期对齐
经营现金流LNKBPBYI
| Q4 25 | $25.3M | $14.4M | ||
| Q3 25 | $23.6M | $9.7M | ||
| Q2 25 | $6.3M | $14.1M | ||
| Q1 25 | $2.6M | $3.6M | ||
| Q4 24 | $25.4M | $15.6M | ||
| Q3 24 | $14.0M | $11.0M | ||
| Q2 24 | $6.4M | $1.0M | ||
| Q1 24 | $-771.0K | $11.2M |
自由现金流LNKBPBYI
| Q4 25 | $23.8M | $14.4M | ||
| Q3 25 | $23.2M | $9.7M | ||
| Q2 25 | $6.1M | $14.1M | ||
| Q1 25 | $2.2M | $3.6M | ||
| Q4 24 | $22.6M | $15.6M | ||
| Q3 24 | $13.1M | $11.0M | ||
| Q2 24 | $6.3M | $1.0M | ||
| Q1 24 | $-1.2M | — |
自由现金流率LNKBPBYI
| Q4 25 | 51.7% | 19.1% | ||
| Q3 25 | 51.8% | 17.7% | ||
| Q2 25 | 14.5% | 26.8% | ||
| Q1 25 | 4.2% | 7.7% | ||
| Q4 24 | 52.6% | 26.4% | ||
| Q3 24 | 30.5% | 13.7% | ||
| Q2 24 | 15.3% | 2.1% | ||
| Q1 24 | -3.0% | — |
资本支出强度LNKBPBYI
| Q4 25 | 3.2% | 0.0% | ||
| Q3 25 | 0.8% | 0.0% | ||
| Q2 25 | 0.4% | 0.0% | ||
| Q1 25 | 0.7% | 0.1% | ||
| Q4 24 | 6.7% | 0.0% | ||
| Q3 24 | 2.1% | 0.0% | ||
| Q2 24 | 0.1% | 0.0% | ||
| Q1 24 | 1.1% | 0.0% |
现金转化率LNKBPBYI
| Q4 25 | 8.59× | — | ||
| Q3 25 | 3.01× | 1.10× | ||
| Q2 25 | 0.85× | 2.41× | ||
| Q1 25 | 0.17× | 1.21× | ||
| Q4 24 | 3.35× | — | ||
| Q3 24 | 1.97× | 0.54× | ||
| Q2 24 | 1.10× | — | ||
| Q1 24 | -0.13× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
